Differential gender responses to hypoglycemia are due to alterations in CNS drive and not glycemic thresholds.

The aims of this study were 1) to determine whether differential glycemic thresholds are the mechanism responsible for the sexual dimorphism present in neuroendocrine responses during hypoglycemia and 2) to define the differences in counterregulatory physiological responses that occur over a range of mild to moderate hypoglycemia in healthy men and women. Fifteen (8 male, 7 female) lean healthy adults underwent four separate randomized 2-h hyperinsulinemic (1.5 mU. kg(-1).min(-1)) glucose clamp studies at euglycemia (90 mg/dl) or hypoglycemia of 70, 60, or 50 mg/dl. Plasma insulin levels were similar during euglycemic and hypoglycemic studies (91-96 +/- 8 microU/ml) in men and women. Hypoglycemia of 70, 60, and 50 mg/dl all resulted in significant increases (P < 0.05, P < 0.01) in epinephrine, glucagon, growth hormone, cortisol, and pancreatic polypeptide levels compared with euglycemic studies in men and women. Plasma norepinephrine levels were increased (P < 0.05) only relative to euglycemic studies at a hypoglycemia of 50 mg/dl. Muscle sympathetic nerve activity (MSNA) increased significantly during hyperinsulinemic-euglycemic control studies. Further elevations of MSNA did not occur until hypoglycemia of 60 mg/dl in both men and women. Plasma epinephrine, glucagon, growth hormone, and pancreatic polypeptide were significantly increased in men compared with women during hypoglycemia of 70, 60, and 50 mg/dl. MSNA, heart rate, and systolic blood pressure responses were also significantly increased in men at hypoglycemia of 60 and 50 mg/dl. In summary, these studies have demonstrated that, in healthy men and women, the glycemic thresholds for activation of epinephrine, glucagon, growth hormone, cortisol, and pancreatic polypeptide occur between 70 and 79 mg/dl. Thresholds for activation of MSNA occur between 60 and 69 mg/dl, whereas norepinephrine is not activated until glycemia is between 50 and 59 mg/dl. We conclude that 1) differential glycemic thresholds are not the cause of the sexual dimorphism present in counterregulatory responses to hypoglycemia; 2) reduced central nervous system efferent input appears to be the mechanism responsible for lowered neuroendocrine responses to hypoglycemia in women; and 3) physiological counterregulatory responses (neuroendocrine, cardiovascular, and autonomic nervous system) are reduced across a broad range of hypoglycemia in healthy women compared with healthy men.

[1]  P. Cryer,et al.  Effect of Hyperketonemia and Hyperlacticacidemia on Symptoms, Cognitive Dysfunction, and Counterregulatory Hormone Responses During Hypoglycemia in Normal Humans , 1994, Diabetes.

[2]  S. Parry,et al.  Redundant parasympathetic and sympathoadrenal mediation of increased glucagon secretion during insulin-induced hypoglycemia in conscious rats. , 1994, Metabolism: clinical and experimental.

[3]  H. Shamoon,et al.  Effect of Antecedent Hypoglycemia on Cognitive Function and on Glycemie Thresholds for Counterregulatory Hormone Secretion in Healthy Humans , 1994, Diabetes Care.

[4]  T. Jones,et al.  Gender influences counterregulatory hormone responses to hypoglycemia. , 1993, Metabolism: clinical and experimental.

[5]  A. Cherrington,et al.  Effects of insulin on the counterregulatory response to equivalent hypoglycemia in normal females. , 1993, The American journal of physiology.

[6]  E. Moberg,et al.  A high concentration of circulating insulin suppresses the glucagon response to hypoglycemia in normal man. , 1991, The Journal of clinical endocrinology and metabolism.

[7]  E A Anderson,et al.  Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. , 1991, The Journal of clinical investigation.

[8]  J. Halter,et al.  Importance of Hepatic Glucoreceptors in Sympathoadrenal Response to Hypoglycemia , 1991, Diabetes.

[9]  I Kiss,et al.  Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. , 1991, The American journal of physiology.

[10]  S. Lightman,et al.  Neurohypophysial secretion to insulin-induced hypoglycemia and its regulation by endogenous opioids in women. , 1990, Acta endocrinologica.

[11]  C. Berne,et al.  Changes of sympathetic nerve activity induced by 2-deoxy-D-glucose infusion in humans. , 1989, The American journal of physiology.

[12]  A. Cherrington,et al.  Role of Brain in Counterregulation of Insulin-Induced Hypoglycemia in Dogs , 1989, Diabetes.

[13]  P. Brunetti,et al.  Modest decrements in plasma glucose concentration cause early impairment in cognitive function and later activation of glucose counterregulation in the absence of hypoglycemic symptoms in normal man. , 1988, The Journal of clinical investigation.

[14]  W. Tamborlane,et al.  Effect of Intensive Insulin Therapy on Glycemic Thresholds for Counterregulatory Hormone Release , 1988, Diabetes.

[15]  W. Tamborlane,et al.  Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitus. , 1987, The New England journal of medicine.

[16]  P. Cryer,et al.  Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. , 1987, The Journal of clinical investigation.

[17]  C. Berne,et al.  Sympathetic Outflow in Human Muscle Nerves Increases During Hypoglycemia , 1986, Diabetes.

[18]  P. Cryer,et al.  Glucose counterregulation during prolonged hypoglycemia in normal humans. , 1984, The American journal of physiology.

[19]  W. Hagopian,et al.  Predominance of renal and absence of hepatic metabolism of pancreatic polypeptide in the dog. , 1983, The American journal of physiology.

[20]  N. Abumrad,et al.  Use of a heated superficial hand vein as an alternative site for the measurement of amino acid concentrations and for the study of glucose and alanine kinetics in man. , 1981, Metabolism: clinical and experimental.

[21]  R. Rodnight,et al.  Assay of plasma catecholamines by liquid chromatography with electrochemical detection. , 1981, Analytical biochemistry.

[22]  B. Wallin,et al.  Plasma noradrenaline correlates to sympathetic muscle nerve activity in normotensive man. , 1981, Acta physiologica Scandinavica.

[23]  R. DeFronzo,et al.  Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.

[24]  R. Sherwin,et al.  Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans. , 1979, The Journal of clinical investigation.

[25]  K. Alberti,et al.  Enzymic fluorometric continuous-flow assays for blood glucose, lactate, pyruvate, alanine, glycerol, and 3-hydroxybutyrate. , 1978, Clinical chemistry.

[26]  A. Cherrington,et al.  Effect of glucagon on glucose production during insulin deficiency in the dog. , 1978, The Journal of clinical investigation.

[27]  D. Johnson,et al.  Glucagon response to hypoglycemia in sympathectomized man. , 1976, The Journal of clinical investigation.

[28]  T. Merimee,et al.  Stabilization of plasma glucose during fasting; Normal variations in two separate studies. , 1974, The New England journal of medicine.

[29]  M Berman,et al.  A model of the kinetics of insulin in man. , 1974, The Journal of clinical investigation.

[30]  G. Blackburn,et al.  Effects of ketone body infusion on hypoglycemic reaction in postabsorptive dogs. , 1974, Metabolism: clinical and experimental.

[31]  R. Ho Radiochemical assay of long-chain fatty acids using 63Ni as tracer. , 1970, Analytical biochemistry.

[32]  R. Unger,et al.  Pancreatic glucagon secretion in normal and diabetic subjects. , 1969, The American journal of the medical sciences.

[33]  J. Porath,et al.  Radioimmunoassay of proteins with the use of Sephadex-coupled antibodies , 1966 .

[34]  F. Greenwood,et al.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. , 1963, The Biochemical journal.

[35]  F. Greenwood,et al.  Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity , 1962, Nature.